{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_1472", "batch_size": 200, "batch_pos": 130, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment uses a vivid verb ('climbed') but it describes a background economic condition (stock price), not the threat's impact.", "method": "llm_batch", "batch_id": "batch_2_16764", "batch_size": 200, "batch_pos": 109, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "'climbed' is a moderate verb + scale, but the segment is about financial metrics, which are Neutral for Q3.", "method": "llm_batch", "batch_id": "batch_3_19048", "batch_size": 200, "batch_pos": 79, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
